Skip to content

Sona Nanotech advances rapid COVID-19 antigen test

August 25, 2020

Thinly traded Sona Nanotech (OTCQB:SNANF +8.2%) is in the green, albeit on turnover of only 10K shares, on the heels of its announcement of performance data on its rapid COVID-19 antigen test.

Based on a bank of 99 patient samples previously analyzed by real-time polymerase chain reaction (RT-PCR) molecular tests, Sona’s assay showed 84.6% sensitivity (detecting true positives) and 90.0% specificity (detecting true negatives).

Applications are in process in Canada and the U.S. seeking emergency use authorizations during the pandemic.

https://seekingalpha.com/news/3608691-sona-nanotech-advances-rapid-covidminus-19-antigen-test

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: